688506 Stock Overview
Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sichuan Biokin Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥172.89 |
| 52 Week High | CN¥205.44 |
| 52 Week Low | CN¥71.01 |
| Beta | 0 |
| 1 Month Change | 11.79% |
| 3 Month Change | 45.07% |
| 1 Year Change | 113.71% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 439.44% |
Recent News & Updates
Shareholder Returns
| 688506 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.0% | -2.7% | -2.6% |
| 1Y | 113.7% | -13.2% | -11.2% |
Return vs Industry: 688506 exceeded the CN Pharmaceuticals industry which returned -13.2% over the past year.
Return vs Market: 688506 exceeded the CN Market which returned -11.2% over the past year.
Price Volatility
| 688506 volatility | |
|---|---|
| 688506 Average Weekly Movement | 8.9% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 688506's share price has been volatile over the past 3 months.
Volatility Over Time: 688506's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,086 | Yi Zhu | www.baili-pharm.com |
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd. Fundamentals Summary
| 688506 fundamental statistics | |
|---|---|
| Market cap | CN¥70.53b |
| Earnings (TTM) | CN¥4.39b |
| Revenue (TTM) | CN¥5.90b |
15.8x
P/E Ratio11.7x
P/S RatioIs 688506 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688506 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.90b |
| Cost of Revenue | CN¥254.33m |
| Gross Profit | CN¥5.65b |
| Other Expenses | CN¥1.25b |
| Earnings | CN¥4.39b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.95 |
| Gross Margin | 95.69% |
| Net Profit Margin | 74.42% |
| Debt/Equity Ratio | 14.5% |
How did 688506 perform over the long term?
See historical performance and comparison